RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Cash and cash equivalents

BOSTON SCIENTIFIC CORPBSX

Market cap
$145B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024606-42.56%
Dec 31, 20231,055-6.31%
Dec 31, 20221,126-48.06%
Dec 31, 20212,168+8.67%
Dec 31, 20201,995+228.67%
Dec 31, 2019607-26.78%
Dec 31, 2018829+322.96%
Dec 31, 2016196-38.56%
Dec 31, 2015319-45.66%
Dec 31, 2014587+170.51%
Dec 31, 2013217+4.83%
Dec 31, 2012207-22.47%
Dec 31, 2011267+25.35%
Dec 31, 2010213

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)